Hong Kong Insurance Stock News

Sun Hung Kai Properties Limited's ( HKG:16 ) investors are due to receive a payment of HK$2.80 per share on 20th of...

Key Insights Given the large stake in the stock by institutions, Biocytogen Pharmaceuticals (Beijing)'s stock price...

Unfortunately for some shareholders, the Reliance Global Holdings Limited ( HKG:723 ) share price has dived 33% in the...

Key Insights Significantly high institutional ownership implies China Mengniu Dairy's stock price is sensitive to their...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

Tai Ping Carpets International Limited's ( HKG:146 ) solid earnings announcement recently didn't do much to the stock...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many...

Lygend Resources & Technology's (HKG:2245) stock is up by a considerable 57% over the past three months. Since the...

Vietnam Manufacturing and Export Processing (Holdings) Limited ( HKG:422 ) shareholders that were waiting for something...

To avoid investing in a business that's in decline, there's a few financial metrics that can provide early indications...

North Asia Strategic Holdings Limited ( HKG:8080 ) shares have continued their recent momentum with a 29% gain in the...

It is hard to get excited after looking at China Feihe's (HKG:6186) recent performance, when its stock has declined 13...

It is hard to get excited after looking at Fufeng Group's (HKG:546) recent performance, when its stock has declined...

Parkson Retail Group Limited ( HKG:3368 ) shares have continued their recent momentum with a 32% gain in the last month...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Edvance International Holdings Limited ( HKG:1410 ) shares have continued their recent momentum with a 29% gain in the...

Unfortunately for some shareholders, the Creative China Holdings Limited ( HKG:8368 ) share price has dived 30% in the...

Shareholders in Pop Mart International Group Limited ( HKG:9992 ) may be thrilled to learn that the analysts have just...

Hong Kong and China Gas (HKG:3) has had a great run on the share market with its stock up by a significant 7.6% over...

With a price-to-earnings (or "P/E") ratio of 60.6x Zhongyu Energy Holdings Limited ( HKG:3633 ) may be sending very...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Earlier this month, CStone Pharmaceuticals received a positive opinion from the European Medicines Agency's CHMP recommending approval of sugemalimab as a monotherapy for adults with unresectable stage III non-small cell lung cancer, following compelling Phase III data from the GEMSTONE-301 trial. This regulatory milestone further strengthens CStone’s clinical track record in oncology and highlights the company’s ability to advance immunotherapies addressing significant unmet needs in...